✦ LIBER ✦

P038 AN OPEN-LABEL TRIAL OF INFLIXIMAB FOR INDUCING AND MAINTAINING CLINICAL AND ENDOSCOPIC REMISSION IN PATIENTS WITH ACUTE, SEVERE ULCERATIVE COLITIS

✍ Scribed by G.J. Mantzaris; A. Roussos; S. Koilakou; A. Christidou; N. Viazis; N. Apostolou; E. Grivas; N. Kanellopoulos; K. Papamichail; G. Agalos; I. Kalafatas; D.G. Karamanolis

Book ID: 119637236
Publisher: Oxford University Press
Year: 2008
Weight: 97 KB
Volume: 2
Category: Article
ISSN: 1873-9954
DOI: 10.1016/s1873-9954(08)70049-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P039 Mucosal interleukin-33 levels in pa

P039 Mucosal interleukin-33 levels in patients with moderate to severe ulcerative colitis before and after induction of endoscopic remission by infliximab

✍ Gundersen, M.D.; Goll, R.; Haraldsen, G.; Florholmen, J.R. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 316 KB

P068 NATALIZUMAB MAINTAINS REMISSION FOR

P068 NATALIZUMAB MAINTAINS REMISSION FOR 2 YEARS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE AND IN THOSE WITH PRIOR INFLIXIMAB EXPOSURE: RESULTS FROM AN OPEN-LABEL EXTENSION STUDY

✍ G. D'Haens; F. Baert; P. Rutgeerts; R. Panaccione 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 58 KB